期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

恶性淋巴瘤相关生物分子的表达及临床应用价值

原文传递
导出
摘要 目前，对于非霍奇金淋巴瘤的认识随着分子生物学和遗传学研究的深入而愈加深化，这有助于我们对淋巴瘤发病机制、诊疗原则、转归与预后更深入的理解和认识，同时也有望成为新的而有前景的治疗靶点。2000年WHO也将其纳入新的淋巴瘤分类标准。本文就非霍奇金淋巴瘤相关生物分子的表达及其应用价值作一综述。
作者 史晓薇(综述) 赵晓英(审校)
机构地区 浙江大学医学院附属第二医院血液科
出处 《国际输血及血液学杂志》 CAS 2009年第2期158-162,共5页 International Journal of Blood Transfusion and Hematology
关键词 淋巴瘤 分子生物学 临床分析 非霍奇金淋巴瘤 分子表达
分类号 R733.4 [医药卫生—肿瘤] R454.2 [医药卫生—治疗学]
  • 相关文献

参考文献32

  • 1Shaffer AL, Yu X, He Y, et al. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control Immunity, 2000, 13(2) :199-212.
  • 2Cleary ML, Smith SD, Sklar J. Cloning and structural analysis of cDNA for bcl-2 and a hubird bcl-2/immunoglobulin transcript resulting from the t ( 14 ; 18) translocation. Cell, 1986, 47 (1) : 19- 28.
  • 3Reed JC, Kitada S, Takayama S, et al. Regulation of chemoresistance by the Bcl-2 oncoprotein in non-Hodgkin lymphoma and lymphocytic leukemia cell lines. Ann Oncol, 1994, 5(Suppl 1) : 61-65.
  • 4Fernandez V, Hartmann E, Ott G, et al. Pathogenesis of mantlecell lymphoma : all onco genic roads lead to dysregulation of cell cycle and DNA damage response pathways. J Clin Oncol, 2005, 23(26) :6364-6369.
  • 5Gladden AB, Woolery R, Aggarwal P, et al. Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B cell lymphoma. Oncogene, 2006, 25(7):998-1007.
  • 6Janz S. Myc translocation in B cell and plasma cell neoplasms. DNA Repair (AMST). 2006, 5(9-10) :1213-1224.
  • 7Takimoto M, Hirakawa T, Oikawa T, et al. Synergistic effects of the myc and ras oncogenes on ganglioside synthesis by BALB/c 3T3 fibroblasts. J Biochem, 1986, 100(3):813-816.
  • 8Zhou H, Du MQ, Dixit VM, et al. Constitutive NF-κ activation by the t ( 11 ; 18) ( q21 ; q21 ) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity. Cancer Cell, 2005, 7(5): 425-431.
  • 9Bischof D, Pulford K, Mason DY, et al. Role of the nucleophosmin(NPM) portion of the non-Hodgkin lymohoma- associated NPM-anaptastic lymphoma kinase fusion protein in oncogenesis. Mol Cell Biol, 1997, 17(4):2312-2325.
  • 10Miething C, Peschel C, Duyster J. Targeting the oncogenie tyrosine kinase NPM ALK in lymphoma: The role of murine models in defining pathogenesis and treatment options. Curr Drug Targets, 2006, 7(10):1329-1334.

二级参考文献13

  • 1李春生,倪灿荣.大肠癌中survivin基因的表达及相关性研究[J].临床与实验病理学杂志,2003,19(2):168-172. 被引量：9
  • 2Ambrosini G,Adida C,Altieri D. A novel anti-apoptosis gene,survivin,expressed in cancer and lymphoma[J]. Nat Med,1997,(8):917-21.
  • 3Nasu S,Yagihashi A,Izawa A,et al. Survivin mRNA expression in patients breast cancer [J]. Anticancer Res,2002,22(3):1839-43.
  • 4Kawasaki H,Toyoda M,Shinohara H,et al. Expression of survivin correlates with apoptosis,proliferation,and angiogenesis during human colorectal tumorigenesis[J]. Cancer,2001,91(11):2026-32.
  • 5Chakravarti A,Noll E,Block PM, et al. Quantitatively determined survivin expression level are of prognotic value in human gliomas[J]. J Clin Oncol,2002,20(4):1063-8.
  • 6Jaffe ES,Harris NL,Stein H,et al. WHO classification of tumors: Pathology and genetics of tumors of haematopoietic and lymphoid tissues[M]. Lyon:IARC Press ,2001:109-253.
  • 7Adida C,Haioun C,Gaulard P, et al. Prognosis significance of survivin expression in diffuse large B-cell lymphoma[J]. Blood,2000,96(5):1921-5.
  • 8Gradilone A,Gazzaniga P,Ribuffo,et al. Survivin,bcl-2,bax,and bcl-X gene expression in sentinel lymph nodes from melanoma patients[J]. J Clin Oncol,2003,21(2):305-12.
  • 9周韧.一种新颖的抗原信号增强方法─BT法在免疫组织化学中的应用[J].中国组织化学与细胞化学杂志,1996,5(3):315-320. 被引量：2
  • 10徐晓丽,殷智榕,黄颖,姜国忠.大肠腺瘤及癌中细胞凋亡和bcl-2、bax基因的表达[J].临床与实验病理学杂志,1998,14(4):328-330. 被引量：13

共引文献20

国际输血及血液学杂志
2009年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部